370 related articles for article (PubMed ID: 30336754)
1. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
Wu Q; Yang Q; Sun H
Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
[TBL] [Abstract][Full Text] [Related]
2. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
3. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
Front Immunol; 2021; 12():663192. PubMed ID: 34054830
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
5. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
6. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus.
Wang H; Cao J; Lai X
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035
[TBL] [Abstract][Full Text] [Related]
7. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
[TBL] [Abstract][Full Text] [Related]
9. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
12. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
[TBL] [Abstract][Full Text] [Related]
14. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
[TBL] [Abstract][Full Text] [Related]
15. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
Front Immunol; 2019; 10():1353. PubMed ID: 31249576
[No Abstract] [Full Text] [Related]
16. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.
Houssiau FA; Lefebvre C; Vanden Berghe M; Lambert M; Devogelaer JP; Renauld JC
Lupus; 1995 Oct; 4(5):393-5. PubMed ID: 8563734
[TBL] [Abstract][Full Text] [Related]
17. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
19. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
[TBL] [Abstract][Full Text] [Related]
20. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
